REVIEW ON ANTI-PARKINSONS DRUGS
Main Article Content
Keywords
Parkinson’s disease, treatment, motor and non-motor symptoms, Anti-Parkinson’s drugs
Abstract
This review the discussion was about the prevalence, awareness, diagnosis, treatment, and control of Parkinson's disease in older adults. Parkinson's Disease is the second most common progressive neurodegenerative disorder affecting older adults Resulting from a pathophysiologic loss or degeneration of dopaminergic neurons in the substantia nigra of the midbrain and the development of neuronal Lewy Bodies, idiopathic Parkinson's Disease is associated with risk factors including aging, family history, pesticide exposure and environmental chemicals (e.g., synthetic heroin use). Its ultimate cause(s) is (are) unknown.Characterized by both motor and non-motor symptoms, PD patients classically display rest tremor, Muscular rigidity, Loss of associated movements, hypokinesia, etc.
References
2. Bhure, Mr Janardhan G., Mr Navab S. Pinjari, and Omkar S. Suryawanshi. "Review On Anti-Hypertensive Agents." Journal of Survey in Fisheries Sciences (2023): 4324-4330.
3. Betarbet R, Sherer TB, Greenamyre JT. Ubiquitin-proteasome system and Parkinson's diseases, ExpNeurol, 2005, vol. 191 (Suppl 1)(pg. 17-27) R
4. Rang & Dale's pharmacology.
5. KD Tripathi. In his book (essential of medical pharmacology)
6. Amos D. Korczyn, ... Tanya Gurevich, in International Encyclopedia of Public Health (Second Edition), 2017
7. Beitz JM. Parkinson's disease: a review. Front Biosci (Schol Ed). 2014 Jan 1;6(1):65-74. doi: 10.2741/s415. PMID: 24389262.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.